The nasal epithelium is a highly permeable monolayer, the sub mucosa is richly vascularised, and hepatic first-pass metabolism is avoided after nasal administration. Other attractive features include the rather large surface area of the nasal cavity and the relatively high blood flow, which promotes rapid absorption. Furthermore, self-medication is easy and convenient.
The Fulvic Acid/liposomal base used by us offers a superior transdermal penetration, and its pathway to the target experiences far less obstacles or loss. Thus, greatly enhancing bioavailability. Further, it is known that Fulvic/liposomal delivery offers considerable potentiation of active ingredients. Thus, the need for active ingredients as the minimum effective concentration (MEC) is much less than comparable actives administered orally, and effective levels can be administered via nasal tissue.